...
机译:血清肿瘤标志物增强了可重置肝内胆管癌中AJCC和LCSGJ分期系统的预测力
Department of Surgery Cleveland Clinic;
Department of Surgery Johns Hopkins Hospital;
Department of Surgery Johns Hopkins Hospital;
Department of Surgery The Ohio State University Wexner Medical Center;
Department of Surgery Johns Hopkins Hospital;
Department of Surgery University of Verona;
Department of Surgery Johns Hopkins Hospital;
Department of Surgery Fundeni Clinical Institute;
Department of Surgery Curry Cabral Hospital;
Department of Surgery Ospedale San Raffaele;
Department of Surgery Emory University;
Department of Surgery Royal Prince Alfred Hospital University of Sydney;
Department of Surgery University of Virginia;
Eastern Hepatobiliary Surgery Hospital;
Department of Surgery Stanford University;
Department of Hepatobiliopancreatic Surgery and Liver Transplantation AP-HP Beaujon Hospital;
Division of General Surgery Department of Surgery University of Ottawa;
Department of Surgery Erasmus University Medical Centre;
Department of Surgery University of Verona;
Gastroenterological Surgery Division Yokohama City University School of Medicine;
Department of Surgery Cleveland Clinic;
Department of Surgery The Ohio State University Wexner Medical Center;
机译:血清肿瘤标志物增强了可重置肝内胆管癌中AJCC和LCSGJ分期系统的预测力
机译:通过掺入血清肿瘤标志物的新分期系统的AJCC第8版分期系统的修改
机译:肿瘤生长类型对肝内胆管癌第七AJCC分期系统的预后影响:659例单中心经验。
机译:非增强腹部CT中肝内胆管癌细分的双层选择性转移学习
机译:肺癌肿瘤AJCC分期指南的预后意义评价
机译:用生物标志物预测的能力:肝内胆管癌中的碳水化合物抗原19-9(CA 19-9)和癌胚抗原(CEA)血清标志物
机译:AJCC第7版TNM分期可准确地区分可切除的肝内胆管癌患者的预后:通过AFC-IHCC-2009研究小组